462 related articles for article (PubMed ID: 26661498)
21. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice.
Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T
Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541
[TBL] [Abstract][Full Text] [Related]
22. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3.
Tsunoda K; Ota T; Aoki M; Yamada T; Nagai T; Nakagawa T; Koyasu S; Nishikawa T; Amagai M
J Immunol; 2003 Feb; 170(4):2170-8. PubMed ID: 12574390
[TBL] [Abstract][Full Text] [Related]
23. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
[TBL] [Abstract][Full Text] [Related]
24. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris.
Lin MS; Swartz SJ; Lopez A; Ding X; Fernandez-Vina MA; Stastny P; Fairley JA; Diaz LA
J Clin Invest; 1997 Jan; 99(1):31-40. PubMed ID: 9011573
[TBL] [Abstract][Full Text] [Related]
25. A single helper T cell clone is sufficient to commit polyclonal naive B cells to produce pathogenic IgG in experimental pemphigus vulgaris.
Takahashi H; Kuwana M; Amagai M
J Immunol; 2009 Feb; 182(3):1740-5. PubMed ID: 19155523
[TBL] [Abstract][Full Text] [Related]
26. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
[TBL] [Abstract][Full Text] [Related]
27. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes.
Aoyama Y; Owada MK; Kitajima Y
Eur J Immunol; 1999 Jul; 29(7):2233-40. PubMed ID: 10427986
[TBL] [Abstract][Full Text] [Related]
28. HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus.
Loiseau P; Lecleach L; Prost C; Lepage V; Busson M; Bastuji-Garin S; Roujeau JC; Charron D
J Autoimmun; 2000 Aug; 15(1):67-73. PubMed ID: 10936030
[TBL] [Abstract][Full Text] [Related]
29. Targeting inducible costimulator expressed on CXCR5
Kim AR; Han D; Choi JY; Seok J; Kim SE; Seo SH; Takahashi H; Amagai M; Park SH; Kim SC; Shin EC; Kim JH
J Allergy Clin Immunol; 2020 Nov; 146(5):1070-1079.e8. PubMed ID: 32311391
[TBL] [Abstract][Full Text] [Related]
30. Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris.
Schlögl E; Radeva MY; Vielmuth F; Schinner C; Waschke J; Spindler V
Front Immunol; 2018; 9():858. PubMed ID: 29922278
[No Abstract] [Full Text] [Related]
31. Heterogeneous MHC II restriction pattern of autoreactive desmoglein 3 specific T cell responses in pemphigus vulgaris patients and normals.
Hertl M; Karr RW; Amagai M; Katz SI
J Invest Dermatol; 1998 Apr; 110(4):388-92. PubMed ID: 9540980
[TBL] [Abstract][Full Text] [Related]
32. Pemphigus vulgaris and its active disease mouse model.
Amagai M
Curr Dir Autoimmun; 2008; 10():167-81. PubMed ID: 18460885
[TBL] [Abstract][Full Text] [Related]
33. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype.
Harman KE; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
Br J Dermatol; 2000 Aug; 143(2):343-8. PubMed ID: 10951143
[TBL] [Abstract][Full Text] [Related]
34. Detection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DR beta 1*0402 tetramers.
Veldman C; Eming R; Wolff-Franke S; Sonderstrup G; Kwok WW; Hertl M
Clin Immunol; 2007 Mar; 122(3):330-7. PubMed ID: 17113829
[TBL] [Abstract][Full Text] [Related]
35. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
[TBL] [Abstract][Full Text] [Related]
36. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
37. Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies.
Calkins CC; Setzer SV; Jennings JM; Summers S; Tsunoda K; Amagai M; Kowalczyk AP
J Biol Chem; 2006 Mar; 281(11):7623-34. PubMed ID: 16377623
[TBL] [Abstract][Full Text] [Related]
38. Anti-desmoglein 3 (Dsg3) monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity.
Yamamoto Y; Aoyama Y; Shu E; Tsunoda K; Amagai M; Kitajima Y
J Biol Chem; 2007 Jun; 282(24):17866-76. PubMed ID: 17428808
[TBL] [Abstract][Full Text] [Related]
39. Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgaris.
Koga H; Tsuruta D; Ohyama B; Ishii N; Hamada T; Ohata C; Furumura M; Hashimoto T
Expert Opin Ther Targets; 2013 Mar; 17(3):293-306. PubMed ID: 23294403
[TBL] [Abstract][Full Text] [Related]
40. Pathogenic human monoclonal antibody against desmoglein 3.
Yeh SW; Cavacini LA; Bhol KC; Lin MS; Kumar M; Duval M; Posner MR; Ahmed AR
Clin Immunol; 2006 Jul; 120(1):68-75. PubMed ID: 16635589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]